Analysts' Weekly Ratings Changes for Regeneron Pharmaceuticals

Analysts' Weekly Ratings Changes for Regeneron Pharmaceuticals


They now have a "hold" rating on the stock. 5/15/2017 - Regeneron Pharmaceuticals had its "hold" rating reaffirmed by analysts at Cowen and Company.



from Biotech News